Press Releases from ARS Therapeutics (1 total)
Major Hospital Accounces Another FDA clinical trial for ALS/Lou Gehrigs Patients …
LOS ANGELES - Feb. 19, 2017 - PRLog -- A major Los Angeles hospital announced another clinical trial of l-serine for ALS/Lou Gehrigs disease patients. This will be the 3rd clinical trial of l-serine, a natural amino acid, for patients with Amyotrophic Lateral Sclerosis. There is clinical evidence that l-serine protects critical motor neauron cells. Enrollment shall commence sometime in 2017. Another FDA approved study of l-serine recently completed…
